HMGB1 and infection: For instance, a study in 2020 illustrated that, through targeting HMGB1 (high-mobility group box-1), a key cytokine that mediates the response to inflammation, injury, and infection, miR-574-5p evidently alleviated acute respiratory distress syndrome (ARDS) [72].